Jeremy Bleicher
Endocrinology, Diabetes & Metabolism · North Miami Beach, FLNPI 1053656561
Payments from drug & device makers
Across 606 payments — averaging $3762.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1.7M
- Endo Pharmaceuticals Inc.$357K
- BD$181K
- Jazz Pharmaceuticals Inc.$27K
- Modernatx, Inc.$8K
- Lilly USA, LLC$867
- plus $4K from 28 others
Across 1 payment — averaging $3180.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- BD$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 281 | $1,703,693 |
| Endo Pharmaceuticals Inc. | 20 | $356,714 |
| BD | 5 | $180,794 |
| Jazz Pharmaceuticals Inc. | 78 | $26,609 |
| Modernatx, Inc. | 3 | $7,875 |
| Lilly USA, LLC | 40 | $867 |
| Insulet Corporation | 25 | $636 |
| Novo Nordisk | 26 | $504 |
| Sanofi-aventis U.S. LLC | 21 | $500 |
| Mannkind Corporation | 18 | $336 |
| AbbVie | 19 | $263 |
| Boehringer Ingelheim | 12 | $255 |
| Valeritas, Inc. | 4 | $156 |
| Johnson & Johnson | 15 | $140 |
| Dexcom, Inc. | 2 | $137 |
| Corcept Therapeutics | 3 | $97 |
| Zealand Pharma US, Inc. | 2 | $90 |
| Amgen(2 entities) | 4 | $74 |
| Cequr Corporation | 2 | $73 |
| Tandem Diabetes Care, Inc. | 3 | $70 |
| Kyowa Kirin, Inc. | 3 | $59 |
| AstraZeneca | 3 | $57 |
| IBSA Pharma Inc. | 2 | $46 |
| Radius Health, Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Sequel Med Tech, LLC | 1 | $31 |
| Amarin Pharma, Inc. | 2 | $27 |
| Recordati_rare_diseases_inc. | 1 | $25 |
| Averitas Pharma Inc. | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Merck | 1 | $15 |
How this compares
$2,280,334 in reported general payments places this provider in the 95th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in North Miami Beach
- Richard PratleyOrlando$9.2M
- Jose MandryOcoee$9.1M
- Steven SmithOrlando$7.9M
- Barry HorowitzWest Palm Beach$7.1M
- Tina ThethiOrlando$3.8M
- David SuttonJacksonville$3.1M
- Lorena Lewy-AlterbaumHollywood$3.1M
- Mae Sheikh AliJacksonville$2.9M
- James MageeJacksonville$2.7M
- Rodolfo GalindoMiami$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.